Study | Randomized method | Sample size (E/C) | BC’s stage | Menstrual cycle | Age | Experimental group | Control group | Duration | Outcomes |
---|---|---|---|---|---|---|---|---|---|
Bailing Shi, 2010;China | Random number table method | 12/13 | N | Post-menopausal | EG: 60.00 ± 4.84 CG: 61.78 ± 3.3 | Traditional Chinese Medicine (TCM) + Aromatase inhibitor(AI) + Calcium tablet | AI+Calcium tablet | 24 w | ⑧ |
Chenlu Liang et al., 2018; China | Random number table method | 42/43 | I II III | Premenopausal | EG: 37.74 ± 6.6 CG: 37.16 ± 6.28 | Black Cohosh+Luteinizing hormone releasing hormone analogue-α(LHRH-α) | LHRH-α | 12 w | ⑧⑨ |
Chen Nie, 2018;China | Not reported | 20/20 | I II | Premenopausal | EG: 41.1 ± 4.3 CG: 43.65 ± 5.36 | Yiqiyangyinjiedu(YQYYJD) formula+Tamoxifen | Tamoxifen | 12 w | ①④⑤⑥ |
Chen Sun, 2009;China | Not reported | 30/30 | N | N | Not reported | Xiaoyaoerxian(XYEX) Decoction+Tamoxifen | Tamoxifen+Oryzanol | 12 w | ①⑦⑧⑨ |
Chen Wang et al.,2019;China | Randomized envelop method | 42/43 | I II III | Premenopausal | EG: 37.74 ± 6.60 CG: 37.16 ± 6.28 | Black Cohosh+LHRH-α | LHRH-α | 12 w | ⑧⑨⑩ |
Cheri L. Van Patten et al.,2002; American | Not reported | 59/64 | I II III | Post-menopausal | EG: 55.5 ± 6.3 CG: 54.9 ± 6.5 | Soy | placebo | 12 w | ⑪ |
Chundi Gao, 2019; China | Random number table method | 24/24 | N | N | EG: 44.13 ± 4.875 CG: 45.25 ± 4.386 | Erxian(EX) Decoction+Tamoxifen | Tamoxifen | 12 w | ①⑦⑧⑨⑩ |
Congshan Li et al., 2021;China | Random number table method | 30/30 | I II III | Premenopausal | EG: 44.18 ± 3.39 CG: 44.97 ± 3.17 | Chaihujialonggumuli(CHJLGML) Decoction+Oryzanol | Oryzanol | 12 w | ①②③④⑤⑥⑦ |
Guilan Tan, 2014;China | simple randomization | 16/16 | I II III | Post-menopausal | EG: 60.36 ± 8.64 CG: 59.00 ± 4.76 | Bushen(BS) formula+AI+Calcium tablet | AI+Calcium tablet | Not reported | ①⑧ |
Haisong Lu et al., 2016;China | Random number table method | 30/30 | N | Premenopausal | EG: 35 ~ 50 CG: 34 ~ 50 | Xiaogeng(XG) powder+Tamoxifen | Tamoxifen+Oryzanol+Vitamin B6 | 8 w | ⑧⑨⑩ |
Han Xiao et al., 2019;China | Random number table method | 25/25 | EG:I1 5 II 11 CG:I1 7 II 10 | Post-menopausal | EG: 60.8 ± 8.7 CG: 62.1 ± 9.4 | Jiaweizhibaidihuang(JWZBDH) Decoction+AI+Oryzanol | AI+Oryzanol | 8 w | ①⑧⑨ |
Hongxia Li et al., 2020; China | Random number table method | 47/49 | EG:I1 1 II 28 III 8 CG:I1 2 II 30 III 7 | Premenopausal | EG: 42.3 ± 6.5 CG: 42.5 ± 7.1 | Qianyangfengsui(QYFS) pellet+Oryzanol | Oryzanol | 12 w | ①⑦⑧ |
Huifen Yang et al., 2015;China | Not reported | 69/33 | N | Premenopausal | Not reported | Erzhi(EZ) pill +Guizhi(GZ) Decoction | Oryzanol | 12 w | ⑧⑨⑩ |
Huifen Yang et al., 2016;China | Random number table method | 69/69 | EG:I 22 II 38 III 9 CG:I 19 II 39 III 11 | Premenopausal | Not reported | Erzhi(EZ) pill +Guizhi(GZ) Decoction | Oryzanol | 8 w | ①⑧⑨⑩ |
Hui Liu et al., 2016;China | Not reported | 34/34 | EG:II 25 III 10 CG:II 33 III 12 | Premenopausal | Not reported | Yiguan(YG) Decoction+LHRH-α + AI | LHRH-α + AI | 12 w | ⑧⑨ |
Hui Zhang,2018; China | Random number table method | 30/30 | EG:I 3 II 14 III 9 IV 4 CG:I 1 II 15 III 11 IV 3 | N | Not reported | Erjialonggu(EJLG) Decoction+Endocrine therapy | Endocrine therapy+Oryzanol | 2 w | ①③④⑤⑥⑦⑧⑨ |
Jingru Song, 2019;China | Random number table method | 27/28 | EG:I 4 II 10 III 6 IV 7 CG:I 5 II 12 III 5 IV 6 | Post-menopausal | EG: 51.44 ± 10.970 CG: 50.75 ± 12.477 | Chaihujialonggumuli(CHJLGML) Decoction+AI | AI | 12 w | ①⑦ |
Juan Zhou,2020; China | Random number table method | 36/36 | N | N | EG: 53.00 ± 6.51 CG: 52.00 ± 5.44 | Xiao yao an kun(XYAK) Decoction+Endocrine therapy | Endocrine therapy+placebo | 8 w | ②③④⑤⑥ |
Judith S. Jacobson et al.,2001; American | Random number table method | 29/30 | N | N | Not reported | Black Cohosh | placebo | 8 w | ⑨⑩⑪ |
Junwen Pei et al., 2019;China | Random number table method | 30/30 | EG:I 4 II 12 III 8 IV 6 CG: I 8 II10 III 7 IV 5 | N | EG: 52.76 ± 8.0 CG: 55.66 ± 7.59 | Danzhixiaoyao(DZXY) powder+Erxian(EX) Decoction+Endocrine therapy | Endocrine therapy | 4 w | ①⑦⑧⑨⑩ |
Junyuan Cai et al., 2021;China | Random number table method | 30/30 | N | Post-menopausal | EG: 61.2 ± 8.5 CG:61.9 ± 9.2 | Fuzhengxiaoliu(FZXL) Decoction | Oryzanol+Vitamin B6 | 8 w | ①⑧⑨⑩ |
Kaili Xu, 2019;China | Not reported | 50/53 | EG:I 20 II 30 CG:I 33 II 30 | N | Not reported | Dangguiliuhuang(DGLH) Decoction+AI | AI | Not reported | â‘ |
Lan Luo et al., 2019;China | simple randomization | 30/30 | N | Premenopausal | EG: 44.07 ± 3.23 CG: 44.37 ± 3.08 | JiaTCMibushen(JPBS) formula+Tamoxifen | Tamoxifen | 4 w | ①④⑤⑥⑪ |
Limin Zhu,2020; China | Random number table method | 61/60 | EG:II47 III 14 CG:II47 III13 | Post-menopausal | EG: 59.43 ± 6.40 CG: 59.7 ± 6.61 | Ruyanning(RYN) formula+AI | AI | 8 w | ①|
Lina Sheng, 2014;China | Not reported | 23/20 | N | N | Not reported | Yangshenshugan(YSSG) Decoction+Endocrine therapy+Oryzanol+Vitamin B1 | Endocrine therapy+Oryzanol+Vitamin B1 | 3 w | ①⑦⑧⑨ |
Liujing Ou, 2018;China | Not reported | 50/50 | N | Post-menopausal | EG: 61.73 ± 5.9 CG: 61.66 ± 5.87 | Bushenquyu (BSQY) formula+AI | AI | 24 w | ①⑦⑧⑪ |
Ming Feng et al.,2021 | Interactive response technology | 45/45 | EG:I 15 II 30 CG:I 18 II 27 | N | EG: 53.8 ± 7.04 CG:51.85 ± 7.84 | Sanhuang(SH) Decoction | None | 24w | ①|
Rongfei Jiang, 2021; China | Not reported | 29/29 | N | N | EG: 51.89 ± 9.97 CG: 55.89 ± 10.58 | Chaihujialonggumuli(CHJLGML) Decoction+Endocrine therapy | Endocrine therapy | 8 w | ①|
Rui Qiang, 2020;China | Random number table method | 36/36 | N | Post-menopausal | EG: 64.3 ± 5.5 CG: 63.7 ± 5.9 | Banxiaxiexin(BXXX) Decoction+Endocrine therapy | Endocrine therapy | 2 w | ⑧⑨⑩ |
Ruiqing Sui, 2019;China | Not reported | 29/30 | N | Post-menopausal | Not reported | Zishuihanmu(ZSHM) formula+Endocrine therapy | Endocrine therapy | 8 w | ①②③⑥ |
Suzhen Lin et al., 2016;China | Not reported | 34/34 | N | Premenopausal | Not reported | Yiguan(YG) Decoction+Tamoxifen | Tamoxifen | 12 w | ②⑤ |
Ting Li et al., 2020;China | Not reported | 36/36 | N | N | EG: 51.88 ± 10.10 CG: 47.69 ± 10.73 | Xiaoyaoankun(XYAK) Decoction+Endocrine therapy | Endocrine therapy+Placebo | 8 w | ②③④⑤⑥⑧⑨ |
Weikang Zhu,2020; China | Not reported | 40/40 | N | Post-menopausal | EG: 64.25 ± 5.67 CG: 60.28 ± 5.88 | Bushenshugan(BSSG) formula+Calcium tablet | Calcium tablet | 24 w | ①⑦⑧⑨⑩⑪ |
Xiaoling Wang, 2018;China | Not reported | 30/30 | N | Premenopausal | EG: 40.66 ± 6.87 CG: 40.73 ± 6.9 | TCM + Oryzanol | Oryzanol | 12 w | ①⑦⑧⑨⑩⑪ |
Xiaomei Wu et al., 2021; China | Random number table method | 39/39 | EG:I 5 II 14 III 13 IV 7 CG:I 6 II 14 III 13 IV 5 | N | EG: 53.44 ± 5.49 CG: 53.38 ± 5.74 | TCM + Oryzanol+Tamoxifen+Vitamin B1 | Oryzanol+Tamoxifen+Vitamin B1 | 12w | ⑧⑨⑩ |
Xiaozhen Liang, 2011; China | Not reported | 40/40 | N | Premenopausal | EG: 47.5 CG: 47 | Liuweidihuang(LWDH) Decoction+Oryzanol | Oryzanol | 8 w | ⑦ |
Yang Fu, 2016; China | Random number table method | 50/50 | EG:I ~ II 26 III ~ IV 24 CG:I ~ II24 III ~ IV 26 | N | EG: 45.1 ± 12.2 CG: 42.9 ± 13.8 | Heixiaoyao(HXY) Powder+Shensiwei(SSW) Decoction+Tamoxifen | Tamoxifen+Oryzanol+Vitamin B1 + Vitamin B6 | 16 w | ①⑧⑨ |
Yemei Li et al., 2022; China | Not reported | 25/25 | EG:I 7 II11 III 7 CG:I 8 II10 III 7 | N | EG: 53.76 ± 8.86 CG: 54.96 ± 8.55 | Jiaweifangjidihuang(JWFJDH) Decoction | Alprazolam | 2 w | ①|
Yining Song et al., 2014;China | Not reported | 60/60 | N | N | Not reported | Black Cohosh | placebo | 12 w | â‘ |
Zhihui Tao et al., 2020;China | Random number table method | 30/30 | EG:I ~ II 24 III ~ IV 6 CG:I ~ II 24 III ~ IV 26 | N | EG: 50.263 ± 5.230 CG:51.566 ± 7.0353 | Yishenkangai(YSKA) formula+Endocrine therapy | Endocrine therapy+Oryzanol | 8 w | ①⑦ |
Zhipei Han et al., 2021; China | Not reported | 40/40 | EG:I 1 II 20 III 15 IV 4 CG:I 2 II 14 III 18 IV 6 | Post-menopausal | EG: 58.93 ± 7.15 CG: 58.80 ± 7.13 | Ruyanning(RYN) formula+AI | AI | 8 w | ①⑧⑨⑩ |
Ziyi Yan, 2021;China | Random number table method | 28/28 | EG:I 4 II 19 III 5 CG:I 8 II 16 III 4 | N | Not reported | Qingxinzishen(QXZS) Decoction+Endocrine therapy | Endocrine therapy | 12 w | ①②③④⑥⑧⑨ |